Erratum: Cucurbitacin B suppresses the transactivation activity of RelA/p65 (Journal of Cellular Biochemistry (2011) 112 (1643-1650) DOI: 10.1002/jcb.23078);Cucurbitacin B suppresses the transactivation activity of RelA/p65

Journal of Cellular Biochemistry

Volumn 112, Issue 6, 2011, Pages 1643-1650

  Jin, Hong Ri ^a,b   Jin, Xuejun ^c   Dat, Nguyen Tien ^d   Lee, Jung Joon ^a,b  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b University of Science and Technology (UST)   (South Korea)

^c YANBIAN UNIVERSITY   (China)

^d GRADUATE UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Viet Nam)

Author keywords

AKT; anti apoptosis; cucurbitacin B; NF B; RELA p65; transactivation

Indexed keywords

CUCURBITACIN; CUCURBITACIN B; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN 1; INHIBITOR OF APOPTOSIS PROTEIN 2; PROTEIN KINASE B; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HELA CELL; HUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 79954566704     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24081     Document Type: Erratum

References (36)

1. Aggarwal BB,. 2004. Nuclear factor-kappaB: The enemy within. Cancer Cell 6: 203-208.
2. Agil A, Miro M, Jimenez J, Aneiros J, Caracuel MD, Garcia-Granados A, Navarro MC,. 1999. Isolation of ani-hepatotoxic principle form the juice of Ecballium elaterium. Planta Med 65: 673-675. (Pubitemid 29503243)
3. Ballard DW, Dixon EP, Peffer NJ, Bogerd H, Doerre S, Stein B, Greene WC,. 1992. The 65-kDa subunit of human NF-kappa B functions as a potent transcriptional activator and a target for v-Rel-mediated repression. Proc Natl Acad Sci USA 89: 1875-1879.
4. Ben-Neriah Y,. 2002. Regulatory functions of ubiquitination in the immune system. Nat Immunol 3: 20-26. (Pubitemid 34065613)
5. Dat NT, Jin X, Hong YS, Lee JJ,. 2010. An isoaurone and other constituents from Trichosanthes kirilowii seeds inhibit hypoxia-inducible factor-1 and nuclear factor-kappaB. J Nat Prod 73: 1167-1169.
6. Ghosh S, Karin M,. 2002. Missing pieces in the NF-kappaB puzzle. Cell 109 (Suppl): S81-96.
7. Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ, Kagnoff MF, Karin M,. 2004. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118: 285-296. (Pubitemid 39061110)
8. Gu C, Ye T, Wells RA,. 2006. Synergistic effects of troglitazone in combination with cytotoxic agents in acute myelogenous leukaemia cells. Leuk Res 30: 1447-1451. (Pubitemid 44307327)
9. Jin HR, Jin X, Lee JJ,. 2010. Zinc-finger protein 91 plays a key role in LIGHT-induced activation of non-canonical NF-kappaB pathway. Biochem Biophys Res Commun 400: 581-586.
10. Karin M, Ben-Neriah Y,. 2000. Phosphorylation meets ubiquitination: The control of NF-[kappa]B activity. Annu Rev Immunol 18: 621-663. (Pubitemid 30365393)
11. Karin M, Greten FR,. 2005. NF-kappaB: Linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5: 749-759. (Pubitemid 41400849)
12. Karin M, Lin A,. 2002. NF-kappaB at the crossroads of life and death. Nat Immunol 3: 221-227.
13. Karin M, Yamamoto Y, Wang QM,. 2004. The IKK NF-kappa B system: A treasure trove for drug development. Nat Rev Drug Discov 3: 17-26. (Pubitemid 38088695)
14. Lee JH, Koo TH, Hwang BY, Lee JJ,. 2002. Kaurane diterpene, kamebakaurin, inhibits NF-kappa B by directly targeting the DNA-binding activity of p50 and blocks the expression of antiapoptotic NF-kappa B target genes. J Biol Chem 277: 18411-18420. (Pubitemid 34952387)
15. Li X, Stark GR,. 2002. NFkappaB-dependent signaling pathways. Exp Hematol 30: 285-296.
16. Liu ZG, Hsu H, Goeddel DV, Karin M,. 1996. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell 87: 565-576. (Pubitemid 26374329)
17. Liu T, Zhang M, Zhang H, Sun C, Deng Y,. 2008. Inhibitory effects of cucurbitacin B on laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol 265: 1225-1232.
18. Madrid LV, Wang CY, Guttridge DC, Schottelius AJ, Baldwin AS Jr, Mayo MW,. 2000. Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB. Mol Cell Biol 20: 1626-1638. (Pubitemid 30100182)
19. Madrid LV, Mayo MW, Reuther JY, Baldwin AS, Jr., 2001. Akt stimulates the transactivation potential of the RelA/p65 subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. J Biol Chem 276: 18934-18940.
20. Mayo MW, Madrid LV, Westerheide SD, Jones DR, Yuan XJ, Baldwin AS, Jr, Whang YE,. 2002. PTEN blocks tumor necrosis factor-induced NF-kappa B-dependent transcription by inhibiting the transactivation potential of the p65 subunit. J Biol Chem 277: 11116-11125. (Pubitemid 34952872)
21. Moon DO, Kim MO, Kang SH, Choi YH, Park SY, Kim GY,. 2010. HA14-1 sensitizes TNF-alpha-induced apoptosis via inhibition of the NF-kappaB signaling pathway: Involvement of reactive oxygen species and JNK. Cancer Lett 292: 111-118.
22. Nagashima K, Sasseville VG, Wen D, Bielecki A, Yang H, Simpson C, Grant E, Hepperle M, Harriman G, Jaffee B, Ocain T, Xu Y, Fraser CC,. 2006. Rapid TNFR1-dependent lymphocyte depletion in vivo with a selective chemical inhibitor of IKKbeta. Blood 107: 4266-4273. (Pubitemid 43801350)
23. Peters RR, Farias MR, Ribeiro-do-Valle RM,. 1997. Anti-inflammatory and analgesic effects of cucurbitacins from Wilbrandia ebracteata. Planta Med 63: 525-528. (Pubitemid 28035447)
24. Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E, Ben-Neriah Y,. 2004. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431: 461-466. (Pubitemid 39329586)
25. Schmitz ML, Baeuerle PA,. 1991. The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B. EMBO J 10: 3805-3817. (Pubitemid 21905409)
26. Sethi G, Sung B, Aggarwal BB,. 2008. Nuclear factor-kappaB activation: From bench to bedside. Exp Biol Med (Maywood) 233: 21-31.
27. Sizemore N, Leung S, Stark GR,. 1999. Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit. Mol Cell Biol 19: 4798-4805. (Pubitemid 29289518)
28. Sizemore N, Lerner N, Dombrowski N, Sakurai H, Stark GR,. 2002. Distinct roles of the Ikappa B kinase alpha and beta subunits in liberating nuclear factor kappa B (NF-kappa B) from Ikappa B and in phosphorylating the p65 subunit of NF-kappa B. J Biol Chem 277: 3863-3869. (Pubitemid 34968637)
29. Thoennissen NH, Iwanski GB, Doan NB, Okamoto R, Lin P, Abbassi S, Song JH, Yin D, Toh M, Xie WD, Said JW, Koeffler HP,. 2009. Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells. Cancer Res 69: 5876-5884.
30. Vallabhapurapu S, Karin M,. 2009. Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol 27: 693-733.
31. Vermeulen L, De Wilde G, Notebaert S, Vanden Berghe W, Haegeman G,. 2002. Regulation of the transcriptional activity of the nuclear factor-kappaB p65 subunit. Biochem Pharmacol 64: 963-970. (Pubitemid 35232270)
32. Wakimoto N, Yin D, O'Kelly J, Haritunians T, Karlan B, Said J, Xing H, Koeffler HP,. 2008. Cucurbitacin B has a potent antiproliferative effect on breast cancer cells in vitro and in vivo. Cancer Sci 99: 1793-1797.
33. Yin D, Wakimoto N, Xing H, Lu D, Huynh T, Wang X, Black KL, Koeffler HP,. 2008. Cucurbitacin B markedly inhibits growth and rapidly affects the cytoskeleton in glioblastoma multiforme. Int J Cancer 123: 1364-1375.
34. Zhang G, Ghosh S,. 2001. Toll-like receptor-mediated NF-kappaB activation: A phylogenetically conserved paradigm in innate immunity. J Clin Invest 107: 13-19. (Pubitemid 32047406)
35. Zhang M, Zhang H, Sun C, Shan X, Yang X, Li-Ling J, Deng Y,. 2009. Targeted constitutive activation of signal transducer and activator of transcription 3 in human hepatocellular carcinoma cells by cucurbitacin B. Cancer Chemother Pharmacol 63: 635-642.
36. Zhong H, May MJ, Jimi E, Ghosh S,. 2002. The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol Cell 9: 625-636. (Pubitemid 34273792)